A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/1992
12/01/1992	CA1310973C .beta.-(FLUOROMETHYLENE)-5-HYDROXYTRYPTOPHAN AND DERIVATIVES AS PRODRUGS FOR MAO INHIBITION
12/01/1992	CA1310968C Indole derivatives
11/1992
11/30/1992	WO1992021660A1 Tricyclic polyhydroxylic tyrosine kinase inhibitors
11/30/1992	WO1992021641A1 Dihydroxyindanone tyrosine kinase inhibitors
11/30/1992	CA2109515A1 Dihydroxyindanone tyrosine kinase inhibitors
11/30/1992	CA2108889A1 Tricyclic polyhydroxylic tyrosine kinase inhibitors
11/30/1992	CA2069520A1 L-carnitine derivatives as therapeutical agents for treating myopathies and neuronal degeneration and for inhibiting proteolysis
11/28/1992	CA2069570A1 6-substituted steroid products containing a thioethyl group in position 10; process for preparing the same and intermediate compounds thereof; their use as therapeutic agents and pharmaceutical products containing them
11/26/1992	WO1992021029A1 Selecting ligand agonists and antagonists
11/26/1992	WO1992020823A1 Backbone modified oligonucleotide analogs
11/26/1992	WO1992020822A1 Backbone modified oligonucleotide analogues
11/26/1992	WO1992020816A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof
11/26/1992	WO1992020796A2 D-type cyclin and uses related thereto
11/26/1992	WO1992020795A1 INHIBITOR OF NF-λB TRANSCRIPTIONAL ACTIVATOR AND USES THEREOF
11/26/1992	WO1992020793A1 CLONING AND RECOMBINANT PRODUCTION OF RECEPTOR(S) OF THE ACTIVIN/TGF-β SUPERFAMILY
11/26/1992	WO1992020749A1 Water-based recording ink
11/26/1992	WO1992020707A1 Bombesin analogs
11/26/1992	WO1992020703A1 The use of nucleic acid analogues in diagnostics and analytical procedures
11/26/1992	WO1992020702A1 Peptide nucleic acids
11/26/1992	WO1992020687A1 Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists
11/26/1992	WO1992020679A1 Benzofuran derivatives
11/26/1992	WO1992020674A1 1h-imidazol-1-yl-methyl benzofuran derivatives, with the imidazolyl moiety being substituted by a cycloalkyl group
11/26/1992	WO1992020673A1 Antihypotensive benzofuran derivatives with n-linked 1h-imidazolylmethyl-5-carboxamide substituents
11/26/1992	WO1992020655A1 Carboxamido-(1,2n)-carbocyclic-2-aminotetralin derivatives
11/26/1992	WO1992020371A1 Targeted delivery of bone growth factors
11/26/1992	WO1992020357A1 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
11/26/1992	WO1992020347A1 2'-fluoro-2-substituted adeninyl arabinosides as anti-cancer agents
11/26/1992	WO1992020344A1 Antiviral combinations containing nucleoside analogs
11/26/1992	WO1992020342A1 Novel composition of angiotensin-ii receptor antagonists and calcium channel blockers
11/26/1992	WO1992020341A1 Method and composition for ameliorating the adverse effects of aging
11/26/1992	WO1992020340A1 Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
11/26/1992	WO1992020335A1 Using allosteric hemoglobin modifiers to decrease oxygen affinity in blood
11/26/1992	WO1992020331A1 Receptor ligands
11/26/1992	WO1992020328A2 Improvements in benzodiazepine treatment by cholinesterase inhibitors
11/26/1992	WO1992020327A1 Treatment of fatigue syndrome with cholinesterase inhibitors
11/26/1992	WO1992020241A1 Nutrient preparation
11/26/1992	CA2109805A1 The use of nucleic acid analogues in diagnostics and analytical procedures
11/26/1992	CA2108880A1 Treatment of fatigue syndrome with cholinesterase inhibitors
11/26/1992	CA2103378A1 Backbone modified oligonucleotide analogues
11/26/1992	CA2103276A1 Novel composition of angiotensin-ii receptor antagonists and calcium channel blockers
11/26/1992	CA2103161A1 D-type cyclin and uses related thereto
11/26/1992	CA2103050A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof
11/26/1992	CA2102801A1 Substituted pyrimidinones bearing acidic functional groups as angiotensin ii antagonists
11/26/1992	CA2102704A1 Inhibitor of nf-kb transcriptional activator and uses thereof
11/26/1992	CA2086327A1 Cloning and recombinant production of receptor(s) of the activin/tgf- .beta. superfamily
11/25/1992	WO1992020700A1 UNSATURATED 17β-SUBSTITUTED 3-CARBOXY STEROIDS
11/25/1992	EP0515302A1 Treatment of fatigue syndrome with cholinesterase inhibitor
11/25/1992	EP0515301A2 Improvements in benzodiazepine treatment by cholinesterterase inhibitors
11/25/1992	EP0515265A1 Pyrimidin derivates, process for their preparation, the obtained intermediates, their use as medicines and the pharmaceutical compositions containing them
11/25/1992	EP0515257A1 1-phenyl-1,4-dihydro-3-hydroxy-4-oxo-pyridazine derivatives, their preparation and their therapeutic use
11/25/1992	EP0515240A1 N-alkylidene piperidine compounds and their enatiomers, process for their preparation and pharmaceutical compositions containing them
11/25/1992	EP0515228A2 Essential pure human parathyroid hormone
11/25/1992	EP0514721A1 Peptides having thrombospondin-like activity and their therapeutic use
11/25/1992	EP0514720A2 Bone growth factors and inhibitors of bone resorption for promoting bone formation
11/25/1992	EP0514481A1 Merosin, nucleic acids encoding, fragments and uses thereof
11/25/1992	CA2087953A1 Unsaturated 17.beta. -substituted 3-carboxy steroids
11/24/1992	US5166416 Propenone oxime ethers, a method of preparing them, and pharmaceutical compositions containing them
11/24/1992	US5166377 Thromboxane A2 antagonist as coagulants or vasoconstrictors
11/24/1992	US5166213 4-pyridyl substituted-1,3-dioxane compounds
11/24/1992	US5166205 Antiallergens or antihistamines with five membered azole ring
11/24/1992	US5166201 2β,19-ethylene bridged steroids as aromatase inhibitors
11/24/1992	US5166175 Treatment of ocular hypertension with a synergistic combination
11/24/1992	US5166136 Antagonist of P undecapeptides as antiinflammatory agents and analgesics and for skin disorders
11/24/1992	US5166133 Antideposit agents or antiinflammatory agents by administering microglobulins
11/24/1992	US5165922 Treatment of breast cancer
11/24/1992	CA2069261A1 Pyrimidine derivatives, their preparation process, the new intermediates obtaines, their application as drugs and the pharmaceutical compositions containing them
11/24/1992	CA1310794C Derivatives of bicyclic amino acids, a process for their preparation, agents containing them and their use
11/24/1992	CA1310793C Nor-statine and nor-cyclostatine polypeptides
11/23/1992	CA2063055A1 Peptides having thrombospondin-like activity and their therapeutic use
11/22/1992	CA2103464A1 Backbone modified oligonucleotide analogs
11/19/1992	EP0514273A1 New derivatives of perhydroisoindole, their preparation and pharmaceutical compositions containing them
11/19/1992	EP0514269A1 Imino-derivatives, process for their preparation and their use in human and veterinary medicine and in cosmetics
11/19/1992	EP0514216A1 Antihypotensive benzofuran derivatives with N-linked 1H-imidazolyl-methyl-5-carboxamide substituents
11/19/1992	EP0514198A1 1H-Imidazol-1-yl-methyl benzofuran derivatives with the imidazolyl moiety being substituted by a cycloalkyl group
11/19/1992	EP0514197A1 Anti-hypertensive benzofuran derivatives substituted by N-imidazolyl-methyl groups which are condensed with optionally nitrogen containing, six-membered rings
11/19/1992	EP0514193A1 N-linked imidazolyl-methyl benzofuran derivatives with antihypotensive activity
11/19/1992	EP0514192A1 Antihypertensive benzofuran derivatives, substituted by varied N-pyrimidinyl- or N-imidazolyl-methyl groups
11/19/1992	EP0514131A1 2-benzazepines with 5-and 6-membered heterocyclic rings
11/19/1992	EP0514130A2 Bone acidic glycoprotein (BAG-75) for inhibiting bone resorption
11/19/1992	EP0514023A1 Use of glycine/NMDA receptor ligands for the manufacture of a medicament for the treatment of drug dependence and withdrawal
11/19/1992	EP0513979A1 Angiotensin II antagonists incorporating a substituted thiophene or furan
11/19/1992	EP0513974A1 Novel benzo-fused lactams that promote the release of growth hormone
11/19/1992	EP0513917A1 Antiviral combinations containing nucleoside analogs
11/19/1992	EP0513878A2 Pharmaceutical compositions containing cationic surfactants
11/19/1992	EP0513862A2 Use of topical applicable preparation for treating skin aging
11/19/1992	EP0513832A1 Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
11/19/1992	EP0513702A2 Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication
11/19/1992	EP0513671A1 Commiphora mukul extracts and therapeutical applications thereof
11/19/1992	EP0513533A2 Heterocyclic substituted phenylacetic-acid derivatives, process for their preparation and their pharmaceutical application
11/19/1992	EP0513434A1 5-//4-/(4',6'-dimethyl-2-pyrimidinyl)sulfamoyl/phenyl/azo/acetylsalicylic acid (DISALAZINE)
11/19/1992	EP0513387A1 Active oxygen inhibitor
11/19/1992	EP0513351A1 2-nitroimidazole derivative, production thereof, and radiosensitizer containing the same as active ingredient
11/19/1992	EP0513334A1 USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-$g(b) FOR BONE REPAIR
11/19/1992	EP0513201A1 Leukocyte-derived growth factor
11/19/1992	EP0513177A1 5-oxygenated-2,4,6-triaminopyrimidines
11/19/1992	DE4116004A1 Naehrstoffzubereitung Naehrstoffzubereitung
11/18/1992	WO1992020653A1 Novel derivatives of perhydroisoindol, their preparation, and pharmaceutical compositions containing them
11/18/1992	CN1019113B 3-aryloxy-3-substituted propanamines
11/18/1992	CA2109298A1 New perhydroisoindole derivatives; process for preparing the same and pharmaceutical compositions containing them
11/17/1992	WO1992020332A1 Pharmaceutical composition comprising purpurogallin useful as an antioxidant and cytoprotective agent

1 ... 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 ... 1564